Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Lcz696 Alleviates Myocardial Fibrosis After Myocardial Infarction Through the sFRP-1/Wnt/β-Catenin Signaling Pathway
Jing Liu, Xuehui Zheng, Chen Zhang, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 27

Showing 1-25 of 27 citing articles:

Ischemia-reperfusion injury: molecular mechanisms and therapeutic targets
Meng Zhang, Qian Liu, Hui Meng, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 175
Wnt Signaling in Heart Development and Regeneration
Dongliang Li, Jianjian Sun, Tao P. Zhong
Current Cardiology Reports (2022) Vol. 24, Iss. 10, pp. 1425-1438
Closed Access | Times Cited: 51
Signaling Pathways and Potential Therapeutic Strategies in Cardiac Fibrosis
Alexandrine Foucault‐Bertaud, Ahmad Joshkon, Xavier Heim, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1756-1756
Open Access | Times Cited: 24
Sacubitril/valsartan in a wide spectrum of heart failure patients (from mechanisms of action to outcomes in specific populations)
Przemyslaw Rajzer, Jan Biegus
Heart Failure Reviews (2025)
Open Access | Times Cited: 1
The role of β-catenin in cardiac diseases
Beibei Ni, Meijuan Sun, Jun Zhao, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 19
Sacubitril/Valsartan Alleviates Cardiac Remodeling and Dysfunction in L-NAME-Induced Hypertension and Hypertensive Heart Disease
Peter Stanko, Kristina Repova, Tomáš Baka, et al.
Biomedicines (2024) Vol. 12, Iss. 4, pp. 733-733
Open Access | Times Cited: 7
Molecular mechanisms of sacubitril/valsartan in cardiac remodeling
Nor Hidayah Mustafa, Juriyati Jalil, Satirah Zainalabidin, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 26
The history and mystery of sacubitril/valsartan: From clinical trial to the real world
Mingsong Zhang, Yifei Zou, Yangxue Li, et al.
Frontiers in Cardiovascular Medicine (2023) Vol. 10
Open Access | Times Cited: 13
Exosomal microRNA‑4516, microRNA‑203 and SFRP1 are potential biomarkers of acute myocardial infarction
Peng Liu, Shuya Wang, Kaiyuan Li, et al.
Molecular Medicine Reports (2023) Vol. 27, Iss. 6
Open Access | Times Cited: 10
Astragaloside IV Alleviates Myocardial Fibrosis After Myocardial Infarction Through SIRT3/β-catenin/PPARγ Signaling Pathway
Jinghu Liu, Hui Zhou, Zhitao Hu, et al.
Pharmacognosy Magazine (2025)
Closed Access
Double crosslinked biomimetic composite hydrogels containing topographical cues and WAY-316606 induce neural tissue regeneration and functional recovery after spinal cord injury
Xingchang Zhao, Xianzhe Lu, Kai Li, et al.
Bioactive Materials (2022) Vol. 24, pp. 331-345
Open Access | Times Cited: 16
Epigenetic regulation of mitochondrial fission and cardiac fibrosis via sFRP3 promoter methylation
S. W. Jiang, Ze‐Yu Zhou, Bin Tu, et al.
Cellular and Molecular Life Sciences (2024) Vol. 81, Iss. 1
Open Access | Times Cited: 3
Qiliqiangxin Modulates the Gut Microbiota and NLRP3 Inflammasome to Protect Against Ventricular Remodeling in Heart Failure
Yingdong Lu, Mi Xiang, Laiyun Xin, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 14
Targeting Myocardial Fibrosis—A Magic Pill in Cardiovascular Medicine?
Alina Scridon, Alkora Ioana Balan
Pharmaceutics (2022) Vol. 14, Iss. 8, pp. 1599-1599
Open Access | Times Cited: 14
Sacubitril/Valsartan and Ivabradine Attenuate Left Ventricular Remodelling and Dysfunction in Spontaneously Hypertensive Rats: Different Interactions with the Renin–Angiotensin–Aldosterone System
Fedor Šimko, Tomáš Baka, Peter Stanko, et al.
Biomedicines (2022) Vol. 10, Iss. 8, pp. 1844-1844
Open Access | Times Cited: 13
Treatment with sacubitril/valsartan effectively manages hypertension and ameliorates left ventricular hypertrophy in hemodialysis patients
Nan Hu, Nan Lv, Yuqing Chen
Blood Purification (2024) Vol. 53, Iss. 8, pp. 657-664
Closed Access | Times Cited: 2
Sacubitril/valsartan alleviates myocardial infarction-induced inflammation in mice by promoting M2 macrophage polarisation via regulation of PI3K/Akt pathway
Nan Jin, Ying Qiu, Kuanxin Zhang, et al.
Acta Cardiologica (2024), pp. 1-10
Closed Access | Times Cited: 2
Sacubitril/valsartan alleviates sepsis‐induced acute lung injury via inhibiting GSDMD‐dependent macrophage pyroptosis in mice
Jun Wang, Jierui Li, Anni Lou, et al.
FEBS Journal (2022) Vol. 290, Iss. 8, pp. 2180-2198
Closed Access | Times Cited: 11
A Combination of an Angiotensin II Receptor and a Neprilysin Inhibitor Attenuates Liver Fibrosis by Preventing Hepatic Stellate Cell Activation
Junya Suzuki, Kosuke Kaji, Norihisa Nishimura, et al.
Biomedicines (2023) Vol. 11, Iss. 5, pp. 1295-1295
Open Access | Times Cited: 6
The Application of Angiotensin Receptor Neprilysin Inhibitor in Cardiovascular Diseases: A Bibliometric Review From 2000 to 2022
Xia Xu, Yumeng Li, Shuqing Shi, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 8
The Rare Condition of Left Ventricular Non-Compaction and Reverse Remodeling
Cristiana Bustea, Alexa Florina Bungău, Delia Mirela Ţiţ, et al.
Life (2023) Vol. 13, Iss. 6, pp. 1318-1318
Open Access | Times Cited: 4
Role of mesenchymal stem cells‐derived exosomes on inflammation, apoptosis, fibrosis and telocyte modulation in doxorubicin‐induced cardiotoxicity: A closer look at the structural level
Reda Abdelnasser Imam, Basma Emad Aboulhoda, Maha M. Amer, et al.
Microscopy Research and Technique (2024) Vol. 87, Iss. 7, pp. 1598-1614
Closed Access | Times Cited: 1
SFRP1 reduces neutrophil infiltration and inhibits the Wnt/β-catenin pathway to alleviate oral submucous fibrosis
Rong Zhou, Lin Yin, Xin Zhang, et al.
In Vitro Cellular & Developmental Biology - Animal (2024) Vol. 60, Iss. 9, pp. 1034-1045
Closed Access | Times Cited: 1
Combination of sacubitril/valsartan and blockade of the PI3K pathway enhanced kidney protection in a mouse model of cardiorenal syndrome
Shunichiro Tsukamoto, Hiromichi Wakui, Tatsuki Uehara, et al.
European Heart Journal Open (2023) Vol. 3, Iss. 6
Open Access | Times Cited: 3
The impact of Sacubitril/Valsartan on cardiac fibrosis early after myocardial infarction in hypertensive rats
Yihai Liu, Chongxia Zhong, Jiayi Si, et al.
Journal of Hypertension (2022) Vol. 40, Iss. 9, pp. 1822-1830
Closed Access | Times Cited: 4
Page 1 - Next Page

Scroll to top